Literature DB >> 18774558

What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?

Raoul Orvieto1, Simion Meltcer, Roy Homburg, Ravit Nahum, Jacob Rabinson, Jacob Ashkenazi.   

Abstract

In an attempt to evaluate the influence of the GnRH analogue used during controlled ovarian hyperstimulation (COH) on the outcome of IVF cycles of polycystic ovary syndrome (PCOS) patients, we studied 152 IVF cycles. The PCOS patients undergoing COH using the GnRH agonist protocol (n = 50) showed a significantly higher pregnancy rate (36% vs. 19.6%, respectively), compared with the GnRH antagonist protocol (n = 102).

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18774558     DOI： 10.1016/j.fertnstert.2008.07.1711

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  9 in total

1.  GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles.

Authors:  Xiang-Hong Zhai; Ping Zhang; Feng-Xia Wu; An-Cong Wang; Pei-Shu Liu
Journal:  Exp Ther Med       Date:  2017-04-05       Impact factor: 2.447

2.  Early initiation of gonadotropin-releasing hormone antagonist in polycystic ovarian syndrome patients undergoing assisted reproduction: randomized controlled trial ISRCTN69937179.

Authors:  Mostafa I Abuzeid; Mohamed Mitwally; Yasmine M Abuzeid; Hammad A Bokhari; Mohammad Ashraf; Michael P Diamond
Journal:  J Assist Reprod Genet       Date:  2012-09-08       Impact factor: 3.412

3.  A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience.

Authors:  Harpreet Kaur; Deepika Krishna; Nivedita Shetty; Sandhya Krishnan; Ms Srinivas; Kamini Arvind Rao
Journal:  J Hum Reprod Sci       Date:  2012-05

4.  Comparison of Endocrine Profile and In Vitro Fertilization Outcome in Patients with PCOS, Ovulatory PCO, or Normal Ovaries.

Authors:  Yi-Ping Zhong; Ying Ying; Hai-Tao Wu; Can-Quan Zhou; Yan-Wen Xu; Qiong Wang; Jie Li; Xiao-Ting Shen; Jin Li
Journal:  Int J Endocrinol       Date:  2012-02-28       Impact factor: 3.257

5.  Treatment Outcome of Ovulation-inducing Agents in Patients with Anovulatory Infertility: A Prospective, Observational Study.

Authors:  Kinjal Prajapati; Mira Desai; Samidh Shah; Sumesh Choudhary; Rohina Aggarwal; Vineet Mishra
Journal:  J Pharmacol Pharmacother       Date:  2017 Jul-Sep

6.  Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.

Authors:  Sally Kadoura; Marwan Alhalabi; Abdul Hakim Nattouf
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.379

7.  First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?

Authors:  Christine Decanter; Geoffroy Robin; Patricia Thomas; Maryse Leroy; Catherine Lefebvre; Benoit Soudan; Valerie Lefebvre-Khalil; Brigitte Leroy-Martin; Didier Dewailly
Journal:  Reprod Biol Endocrinol       Date:  2013-06-19       Impact factor: 5.211

8.  Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs.

Authors:  Haiyan Lin; Yu Li; Lin Li; Wenjun Wang; Dongzi Yang; Qingxue Zhang
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

9.  Comparison of gonadotropin-releasing hormone agonist with GnRH antagonist in polycystic ovary syndrome patients undergoing in vitro fertilization cycle: Retrospective analysis from a tertiary center and review of literature.

Authors:  Neeta Singh; Moumita Naha; Neena Malhotra; Kusum Lata; P Vanamail; Abnish Tiwari
Journal:  J Hum Reprod Sci       Date:  2014-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.